John F. Donovan

Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use

Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN.

Greenwich Technology Partners, Inc. provides network infrastructure consulting and engineering services. It designs, builds and manages complex networks that utilize advanced Internet protocol, electro/optical, and other sophisticated technologies. The firm's clients include service providers, Global 2000 enterprises and select Internet companies. The company was co-founded by Joseph P. Beninati & James P. Cabrera in 1997 and is headquartered in White Plains, NY.

Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA.

Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA.

Axiom Global, Inc. engages in the provision of legal services. Its solution areas include privacy, contracts, intellectual property, corporate and securities, labor and employment, regulation and compliance, real estate, mergers and acquisition, derivatives, and litigation. It serves to the technology, life sciences, industrials, and consumer and financial services industries. The company was founded by Mark Harris and Alexander Guettel in 2000 and is headquartered in New York. NY.

Boka Sciences, Inc provides biotechnology services. It develops human hydration assessment tests using biomarkers. The company was founded by Andrew Byars and is headquartered in Santa Barbara, CA.

Ten TV, Inc. provides video-based online communications services for businesses. The company is headquartered in Ardsley, NY.

The Hillman Cos., Inc. engages in the manufacture and distribution of hardware related products. Its products include fasteners; threaded rod and metal shapes; keys, key duplication systems, and accessories; builder's hardware; and identification items, such as tags and letters, numbers, and signs. The company was founded in 1964 and is headquartered in Cincinnati, OH.

The Hillman Group, Inc. provides hardware-related products and merchandising services to retail markets. Its products include fasteners, key duplication systems, engraved tags, builder's hardware, roller chain, and magnets and magnet tools. The firm supports its product sales with value added services including design and installation of merchandising systems and maintenance of appropriate in-store inventory levels. The company was founded by Max W. Hillman Sr. in 1964 and is headquartered in Cincinnati, OH.

Part of Edelman Financial Engines LLC, Crest Advisors LLC provides corporate finance services. The company is based in New York, NY. The company was founded by William W. Sprague, Gregg A. Mockenhaupt. Crest Advisors was acquired by Pinnacle Summer Investments, Inc. on April 22, 2004.

CCMP Capital Advisors LP (CCMP Capital Advisors) is a private equity firm, a subsidiary of CCMP Capital LP founded in 1984. The firm is headquartered in New York with additional offices in London.

Part of TOLMAR Holding, Inc., Zila Pharmaceuticals, Inc. manufactures medicinal products. The company is based in Phoenix, AZ.

Indalo Ventures LLC provides advisory and investment services. The firm offers corporate finance and strategic advisory services. The company was founded by Frank J. Bellizzi and is headquartered in San Francisco, CA.

Part of Hillman Solutions Corp., HMAN Group Holdings, Inc. is a company committed to building an inclusive and equitable workplace where diversity is valued and leveraged. The company is based in New York, NY. The company's mission is to empower those who relentlessly build for tomorrow. Hillman is an industry leader in builder solutions, building stronger partnerships with the customers they serve.

Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA.

BIM Networks, Inc. operates a payment and commerce platform. The CEO is Adam B. Frisch.

Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom.

Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA.

VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland.